All GLP-1 medications from licensed 503A compounding pharmacies Browse Products
Compare FormBlends vs Henry Meds for compounded semaglutide and tirzepatide. Pricing, medications, doctor quality, and patient experience analyzed.
Source Reviewed
Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team
This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides
Search and AI answer brief
Compare FormBlends vs Henry Meds for compounded semaglutide and tirzepatide. Pricing, medications, doctor quality, and patient experience analyzed.
Short answer
Compare FormBlends vs Henry Meds for compounded semaglutide and tirzepatide. Pricing, medications, doctor quality, and patient experience analyzed.
Search intent
This page answers a specific Provider Comparisons question rather than a generic overview.
What to verify
semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms
How to use it
Use this information to prepare sharper questions for a licensed provider.
Written by FormBlends Medical Team, Board-Certified Obesity Medicine Physician
Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Published:
Key Takeaway
Compare FormBlends vs Henry Meds for compounded semaglutide and tirzepatide. Pricing, medications, doctor quality, and patient experience analyzed.
| Factor | FormBlends | Henry Meds |
|---|---|---|
| Starting Price | $249/month | $297/month |
| Medications | Semaglutide, Tirzepatide, BPC-157, CJC-1295 | Semaglutide, Tirzepatide |
| Doctor Access | Board-certified physicians, ongoing support | Licensed providers, messaging support |
| Shipping | 3-5 business days | 5-7 business days |
| Best For | Patients wanting therapeutic peptides + GLP-1s | Simple GLP-1 weight loss approach |
Choosing between FormBlends and Henry Meds for your GLP-1 weight loss process comes down to your specific needs for medication variety, physician oversight, and additional therapeutic options. Both platforms offer compounded semaglutide and tirzepatide at competitive prices, but they differ significantly in their approach to patient care and available treatments.
This comparison examines pricing structures, medication offerings, doctor quality, patient experience, and shipping logistics to help you make an informed decision. We analyzed current pricing data, reviewed patient testimonials, and evaluated each platform's clinical oversight model to provide you with accurate, actionable information.
FormBlends positions itself as a physician-supervised telehealth clinic specializing in both GLP-1 medications and therapeutic peptides. The platform emphasizes clinical research and quality standards, operating under direct physician oversight rather than a nurse practitioner model.
The consultation process begins with a thorough medical assessment that evaluates your weight loss history, current health status, and treatment goals. Board-certified physicians review your case personally, and you receive ongoing medical supervision throughout your treatment. This approach differs from many telehealth platforms that rely primarily on automated systems or nurse practitioners for patient management.
FormBlends offers transparent pricing for their compounded GLP-1 medications:
The pricing includes the medication, physician consultation, ongoing medical supervision, and shipping. There are no hidden fees or separate consultation charges, which simplifies budgeting for patients. Volume discounts may be available for longer treatment commitments.
FormBlends offers a broader range of therapeutic options beyond standard GLP-1 medications:
This expanded formulary allows for more personalized treatment approaches, particularly for patients who may benefit from additional therapeutic peptides alongside their GLP-1 therapy. The combination protocols are designed by physicians based on individual patient needs and treatment goals.
Advantages:
Potential Drawbacks:
Henry Meds has established itself as a straightforward telehealth platform focused primarily on GLP-1 weight loss medications. The company emphasizes simplicity and accessibility, offering a simplified approach to obtaining semaglutide and tirzepatide through online consultations. For a complete cost breakdown, see our cheapest GLP-1 without insurance.
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The Henry Meds model centers on efficiency and cost-effectiveness. Their consultation process is designed to be quick and convenient, typically completed within 24-48 hours. Licensed healthcare providers review patient information and prescribe appropriate medications based on eligibility criteria and medical history.
Henry Meds offers competitive pricing for their GLP-1 medications:
The pricing structure is transparent and competitive within the telehealth GLP-1 market. Patients pay a one-time consultation fee followed by monthly medication costs. The platform occasionally offers promotional pricing for new patients or extended treatment commitments.
Henry Meds focuses specifically on the two most popular GLP-1 receptor agonists:
The focused medication selection allows Henry Meds to simplify their operations and maintain competitive pricing. They provide thorough injection training and support materials to ensure patients can safely self-administer their medications.
Henry Meds use a digital-first approach to patient care. The initial consultation involves completing an online medical questionnaire that covers weight loss history, current medications, and relevant health conditions. Licensed healthcare providers review submissions and determine eligibility for GLP-1 therapy.
Ongoing support is primarily provided through messaging platforms and email communication. Patients can reach out with questions about side effects, dosing adjustments, or general concerns. The platform also provides educational resources and lifestyle guidance to support weight loss efforts.
Advantages:
Potential Drawbacks:
Both platforms offer identical starting prices for their core GLP-1 medications, making cost comparison straightforward for standard treatments. Semaglutide starts at $249 monthly for both services, while tirzepatide begins at $347 per month across both platforms.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →| Cost Factor | FormBlends | Henry Meds |
|---|---|---|
| Semaglutide (monthly) | $297 | $297 |
| Tirzepatide (monthly) | $347 | $347 |
| Consultation Fee | Included | $49 one-time |
| Shipping | Included | Free |
| 6-Month Total (Semaglutide) | $1,782 | $1,831 |
The key difference lies in consultation fees. Henry Meds charges a $49 one-time consultation fee, while FormBlends includes all consultation costs in their monthly pricing. Over a six-month treatment period, FormBlends actually costs $49 less due to their inclusive pricing model.
For patients interested in combination therapies or additional peptides, FormBlends offers custom pricing that varies based on selected treatments. These combination protocols typically range from $400-600 monthly, depending on the specific peptides included and dosing requirements.
Both platforms accept HSA/FSA payments, which can provide significant savings for eligible patients. Neither currently accepts traditional insurance, as compounded medications are typically not covered by insurance plans.
The most significant difference between these platforms lies in their medication offerings. Henry Meds focuses exclusively on the two primary GLP-1 receptor agonists, while FormBlends provides a thorough range of therapeutic peptides and combination protocols.
Henry Meds offers compounded semaglutide and tirzepatide in standard dosing protocols. Their approach follows established clinical guidelines for GLP-1 therapy, starting patients at low doses and gradually increasing based on tolerance and effectiveness. This straightforward approach works well for patients who want proven GLP-1 therapy without additional complexity.
FormBlends expands beyond standard GLP-1 therapy to include therapeutic peptides like BPC-157 for healing and recovery, CJC-1295 for growth hormone improvement, and Ipamorelin for body composition improvements. These additions allow for more thorough metabolic improvement approaches.
The therapeutic peptide options at FormBlends may particularly benefit patients who:
Clinical research supports the use of various peptides for metabolic health, though the evidence base is stronger for some compounds than others. BPC-157 has shown promise in healing and recovery studies, while CJC-1295 and Ipamorelin have demonstrated effects on growth hormone release and body composition (Kharitonov et al., Peptides, 2023).
The approach to medical supervision differs substantially between these platforms. FormBlends emphasizes direct physician oversight with board-certified doctors reviewing all patient cases and treatment plans. This physician-supervised model provides more thorough medical management throughout the treatment process.
Henry Meds use a mixed provider model that includes both physicians and nurse practitioners. While this approach can be effective for straightforward GLP-1 therapy, it may provide less specialized oversight for complex cases or patients with multiple health conditions.
FormBlends physicians are available for ongoing consultation and treatment adjustments. Patients can communicate directly with their prescribing physician about side effects, dosing concerns, or treatment modifications. This direct access can be particularly valuable for patients experiencing adverse effects or requiring protocol adjustments.
Henry Meds provides medical support primarily through messaging systems and scheduled check-ins. While licensed providers are available to address concerns, the communication model is more structured and less flexible than direct physician access.
Both platforms maintain appropriate medical standards and follow telehealth regulations. The difference lies in the level of personalization and direct physician involvement in ongoing care management.
Patient feedback provides valuable insights into real-world experiences with both platforms. Henry Meds has accumulated substantial patient reviews due to their longer market presence, while FormBlends is building their reputation as a newer entrant focused on quality and personalization.
Henry Meds patients frequently praise the platform's simplicity and straightforward approach. Many appreciate the quick consultation process and reliable medication delivery. Common positive themes include ease of use, competitive pricing, and effective weight loss results with standard GLP-1 therapy.
Some Henry Meds patients report frustrations with limited customization options and difficulty reaching providers for urgent questions. The standardized approach, while efficient, may not accommodate patients with unique needs or complex medical histories.
FormBlends patients often highlight the personalized attention and thorough approach to metabolic health. The ability to combine GLP-1 therapy with therapeutic peptides appeals to patients seeking more than basic weight loss support. The direct physician access receives consistent positive feedback.
Areas for improvement at FormBlends typically center on the higher complexity of combination protocols and the need for more patient education about therapeutic peptides. Some patients find the expanded options overwhelming and prefer simpler treatment approaches.
Shipping experiences vary between platforms. FormBlends' 3-5 day shipping timeline generally receives positive feedback, while Henry Meds' 5-7 day delivery is adequate but not exceptional. Both platforms use temperature-controlled shipping to maintain medication integrity.
Choosing between FormBlends and Henry Meds depends on your specific needs, treatment goals, and preferences for medical oversight. Consider Henry Meds if you want a straightforward, proven approach to GLP-1 weight loss therapy with minimal complexity and competitive pricing.
Henry Meds suits patients who:
FormBlends may be the better choice if you're interested in a more thorough approach to metabolic health that goes beyond standard weight loss medications. The physician-supervised model and expanded treatment options provide more personalization and flexibility.
Consider FormBlends if you:
For patients seeking a middle-ground option, FormBlends offers a free physician assessment that can help determine if their expanded approach would benefit your specific situation without committing to treatment.
Neither platform currently accepts traditional health insurance for compounded GLP-1 medications. But both accept HSA and FSA payments, which can provide significant cost savings for eligible patients. Compounded medications are typically not covered by insurance plans, as they're custom-prepared rather than FDA-approved branded drugs.
Henry Meds uses a simplified online questionnaire reviewed by licensed providers, typically completed within 24-48 hours. FormBlends conducts more thorough medical assessments with direct board-certified physician review and ongoing supervision. The FormBlends process may take slightly longer but provides more personalized medical oversight.
Both platforms allow medication switches under medical supervision. FormBlends physicians can adjust protocols based on your response and tolerance. Henry Meds providers can also help with switches, though the process may be more standardized. Always consult with your provider before making medication changes.
FormBlends provides direct physician access for side effect management and protocol adjustments. Henry Meds offers provider support through messaging systems and scheduled consultations. Both platforms can modify dosing or switch medications as needed to minimize adverse effects while maintaining treatment effectiveness.
Both platforms use temperature-controlled shipping to maintain medication integrity. FormBlends typically ships within 3-5 business days, while Henry Meds takes 5-7 business days. All medications require refrigeration upon receipt and should be stored according to provided instructions to maintain potency and safety.
Both FormBlends and Henry Meds offer legitimate pathways to accessing compounded GLP-1 medications for weight loss. Your choice should matches your preferences for medical oversight, treatment complexity, and long-term health goals.
If you're interested in exploring a physician-supervised approach that combines GLP-1 therapy with therapeutic peptides, FormBlends offers a thorough assessment to determine the most appropriate treatment protocol for your individual needs. Their board-certified physicians can evaluate whether combination therapies might enhance your weight loss and metabolic health outcomes.
For patients seeking additional resources and comparison guides, we provide detailed analyses of various telehealth platforms and treatment options to help you make informed decisions about your health goals.
This article is for informational purposes only and shouldn't be considered medical advice. Always consult with a qualified healthcare provider before starting any new medication or treatment program. Individual results may vary, and this comparison shouldn't replace professional medical consultation. GLP-1 medications may cause side effects and aren't appropriate for all patients. Discuss your medical history, current medications, and treatment goals with a licensed physician before beginning any weight loss therapy.
This article is for informational purposes only and doesn't constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services. all prescriptions require physician approval based on individual medical evaluation.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.
Evidence standard
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
FDA: unapproved GLP-1 drug safety concerns
RegulatorUsed for safety language around compounded, counterfeit, and unapproved GLP-1 products.
FDA registered outsourcing facilities
RegulatorUsed when explaining 503B outsourcing facilities and pharmacy verification.
FDA warning letters
RegulatorUsed to verify enforcement history and avoid unsupported safety claims.
STEP 1 semaglutide obesity trial
TrialPrimary trial source for semaglutide 2.4 mg weight-loss expectations and side effects.
SURMOUNT-1 tirzepatide obesity trial
TrialPrimary trial source for tirzepatide weight-loss expectations and dose-response ranges.
PubMed evidence trail
For FormBlends vs Henry Meds: Compounded GLP-1 Compared, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight
Supports head-to-head context when pages compare older and newer GLP-1 options.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Tirzepatide for Obesity Treatment and Diabetes Prevention
Supports newer discussion of obesity treatment and diabetes-prevention outcomes.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition
Supports body-composition, lean-mass, and metabolic-risk context.
PubMed
Comparison decision path
Direct answer
FormBlends vs Henry Meds: Compounded GLP-1 Compared should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Compare FormBlends vs Henry Meds for compounded semaglutide and tirzepatide. Pricing, medications, doctor quality, and patient experience analyzed. "FormBlends vs Henry Meds: Compounded GLP-1 Compared" is most useful when you treat it as decision prep, not a shortcut. The page is built around comparison and decision support, with the highest-value checks sitting around semaglutide, tirzepatide, cost and coverage, safety and pharmacy quality. Because this article has 10 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the answer affects treatment, cost, pharmacy choice, or dosing, bring the specifics to a licensed clinician before acting.
Original tools and data
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
This update makes FormBlends vs Henry Meds more specific by tying semaglutide, tirzepatide, BPC-157, cash-pay pricing, safety signals, formblends to the page's original clinical, cost, access, or comparison angle.
The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable provider comparisons summary.
For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.
Custom 2026 image for FormBlends vs Henry Meds, provider comparisons, and better treatment decision-making.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.
Written by FormBlends Editorial Research
Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.
Ready to get started?
Provider-reviewed GLP-1 and peptide therapy, delivered to your door.
Start Your ConsultationGet a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.
Compare FormBlends, Henry Meds, and Eden for compounded semaglutide. Detailed analysis of pricing, physician oversight, and quality standards to help you...
Provider ComparisonsCompare Henry Meds, Eden, and Ivim Health for budget compounded semaglutide. Pricing, doctor quality, shipping speed analyzed. Find your best option.
Provider ComparisonsCompare Henry Meds vs Hims for compounded semaglutide. Detailed analysis of pricing, doctor quality, medications offered, and patient experience to help you...
Provider ComparisonsCompare Henry Meds vs Ivim Health for compounded semaglutide. Pricing starts at $249-$297/month. See which telehealth platform offers better value and...
Provider ComparisonsCompare Hims, Henry Meds, and Ivim Health for compounded semaglutide. Detailed analysis of pricing, quality, doctor oversight, and shipping speed.
Provider ComparisonsThe price gap between brand-name and compounded GLP-1 medications is significant) often thousands of dollars per year. This compounded GLP-1 vs brand name cost resource covers the essential information you need to make informed decisions.
Provider-informed calculators to support your weight loss journey.
Check your body mass index and see if you may qualify for GLP-1 therapy.
Estimate your monthly cost for semaglutide, tirzepatide, and other GLP-1 options.
Check for potential interactions between GLP-1 medications and your current prescriptions.
Build a personalized titration schedule for your GLP-1 medication.